Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer.

Journal: Cancer Cell

Published: 2020-06-02

DOI: 10.1016/j.ccell.2020.05.010

Affiliations: 26

Authors: 44

Go to article
Institutions Share
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA) 0.24
Human Oncology and Pathogenesis Program (HOPP), MSKCC, United States of America (USA) 0.21
Cancer Biology and Genetics Program (CBG), MSKCC, United States of America (USA) 0.10
Stony Brook Medicine, SUNY Stony Brook, United States of America (USA) 0.10
UNC Lineberger Comprehensive Cancer Center, United States of America (USA) 0.05
The University of North Carolina at Chapel Hill (UNC), United States of America (USA) 0.05
Dana-Farber Cancer Institute (DFCI), United States of America (USA) 0.05
University Hospital of Münster (UKM), WWU, Germany 0.05
University of Münster (WWU), Germany 0.05
Broad Institute of MIT and Harvard, United States of America (USA) 0.02
Fred Hutchinson Cancer Research Center (FHCRC), United States of America (USA) 0.02
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany 0.02
University of Glasgow, United Kingdom (UK) 0.02
The Kinghorn Cancer Centre (TKCC), Australia 0.01
Bankstown-Lidcombe Hospital, Australia 0.01
University of New South Wales (UNSW Sydney), Australia 0.01
Dartmouth-Hitchcock Medical Center (DHMC), United States of America (USA) 0.01
Yale University, United States of America (USA) 0
Universidad del Cauca, Colombia 0

Return